Virginia Barbour
Virginia Barbour
Verified email at Qut.edu.au
Title
Cited by
Cited by
Year
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
KF Schulz, DG Altman, D Moher, Consort Group
Trials 11 (1), 32, 2010
94932010
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials
D Moher, S Hopewell, KF Schulz, V Montori, PC Gøtzsche, PJ Devereaux, ...
International journal of surgery 10 (1), 28-55, 2012
63652012
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Bmj 348, 2014
27622014
Reprint—preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Moher, A Liberati, J Tetzlaff, DG Altman, Prisma Group
Physical therapy 89 (9), 873-880, 2009
1228*2009
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration
S Hopewell, M Clarke, D Moher, E Wager, P Middleton, DG Altman, ...
PLoS Med 5 (1), e20, 2008
4902008
Can the national addiction treatment infrastructure support the public’s demand for quality care
AT McLellan, D Carise, HD Kleber
Journal of substance abuse treatment 25 (2), 117-121, 2003
4482003
Potential predatory and legitimate biomedical journals: can you tell the difference? A cross-sectional comparison
L Shamseer, D Moher, O Maduekwe, L Turner, V Barbour, R Burch, ...
BMC medicine 15 (1), 1-14, 2017
1722017
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
D Mother, A Liberati, J Tetzlaff, D Altman
PLoS Med 6 (7), e1000097, 2009
1372009
UK Biobank: a project in search of a protocol?
V Barbour
The Lancet 361 (9370), 1734-1738, 2003
1082003
Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration
V Welch, M Petticrew, J Petkovic, D Moher, E Waters, H White, P Tugwell, ...
Journal of clinical epidemiology 70, 68-89, 2016
882016
Retractions: guidance from the Committee on Publication Ethics (COPE)
E Wager, V Barbour, S Yentis, S Kleinert
Maturitas 64 (4), 201-203, 2009
832009
Nephrotic syndrome associated with sulphasalazine.
VM Barbour, PF Williams
BMJ: British Medical Journal 301 (6755), 818, 1990
691990
α-Thalassemia resulting from a negative chromosomal position effect
VM Barbour, C Tufarelli, JA Sharpe, ZE Smith, H Ayyub, CA Heinlein, ...
Blood, The Journal of the American Society of Hematology 96 (3), 800-807, 2000
472000
Optimal evidence in difficult settings: improving health interventions and decision making in disasters
M Gerdin, M Clarke, C Allen, B Kayabu, W Summerskill, D Devane, ...
PLoS Med 11 (4), e1001632, 2014
432014
How ghost-writing threatens the credibility of medical knowledge and medical journals
V Barbour
haematologica 95 (1), 1-2, 2010
392010
Targeted disruption of the CP2 gene, a member of the NTF family of transcription factors
L Ramamurthy, V Barbour, A Tuckfield, DR Clouston, D Topham, ...
Journal of Biological Chemistry 276 (11), 7836-7842, 2001
372001
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
TC Hoffmann, PP Glasziou, I Boutron, R Milne, R Perera, D Moher, ...
Gesundheitswesen (Bundesverband der Arzte des Offentlichen …, 2016
36*2016
Ten simple rules for building and maintaining a scientific reputation
PE Bourne, V Barbour
PLoS comput biol 7 (6), e1002108, 2011
362011
Defective extraembryonic angiogenesis in mice lacking LBP-1a, a member of the grainyhead family of transcription factors
V Parekh, A McEwen, V Barbour, Y Takahashi, JE Rehg, SM Jane, ...
Molecular and cellular biology 24 (16), 7113-7129, 2004
332004
Core competencies for scientific editors of biomedical journals: consensus statement
D Moher, J Galipeau, S Alam, V Barbour, K Bartolomeos, P Baskin, ...
BMC medicine 15 (1), 167, 2017
322017
The system can't perform the operation now. Try again later.
Articles 1–20